Ipilimumab and Nivolumab for Treatment of Eyelid Spindle Cell Melanoma

被引：2
|
作者：
Shoji, Marissa K. [1 ,2 ]
Rong, Andrew J. [1 ,2 ]
机构：
[1] Univ Miami, Bascom Palmer Eye Inst, Miller Sch Med, Miami, FL USA
[2] Univ Miami, Bascom Palmer Eye Inst, Miller Sch Med, 900 NW 17th St, Miami, FL 33136 USA
来源：
AMERICAN JOURNAL OF OPHTHALMOLOGY | 2023年 / 250卷
关键词：
D O I：
10.1016/j.ajo.2023.02.010
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E1 / E2
页数：2
相关论文
共 50 条
  • [31] Milestones in the Treatment of malignant Melanoma Nivolumab in the Adjuvant and as a Combination Therapy with Ipilimumab in Patients with advanced Melanoma
    Sankawa, Yuri
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (7-8) : 414 - 415
  • [32] Effective management of lung spindle cell carcinoma with ipilimumab, nivolumab, carboplatin, and paclitaxel, demonstrating efficacy in brain metastases treatment
    Noguchi, Susumu
    Okamoto, Atsushi
    Nohara, Jun
    Ishitoko, Manabu
    Watanabe, Toshiki
    Nakamura, Takaya
    RESPIROLOGY CASE REPORTS, 2024, 12 (05):
  • [33] Case Report: Neuromyelitis Optica After Treatment of Uveal Melanoma With Nivolumab and Ipilimumab
    Khimani, Karima
    Patel, Sapna P.
    Whyte, Andrew
    Al-Zubidi, Nagham
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] Autoimmune polyradiculitis due to combination immunotherapy with ipilimumab and nivolumab for the treatment of metastatic melanoma
    Lasocki, Arian
    Smith, Kortnye
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 74 : 240 - 241
  • [35] COST EFFECTIVENESS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE TREATMENT OF ADVANCED MELANOMA PATIENTS IN ENGLAND
    Lee, D.
    Amadi, A.
    Sabater, J.
    Ellis, J.
    Johnson, H.
    Roskell, N.
    Meng, Y.
    Patterson, K.
    VALUE IN HEALTH, 2016, 19 (07) : A731 - A731
  • [36] Severe hepatitis arising from ipilimumab administration, following melanoma treatment with nivolumab
    Tanaka, Ryota
    Fujisawa, Yasuhiro
    Sae, Inoue
    Maruyama, Hiroshi
    Ito, Shusaku
    Hasegawa, Naoyuki
    Sekine, Ikuo
    Fujimoto, Manabu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (02) : 175 - 178
  • [37] Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience
    Karivedu, Vidhya
    Eldessouki, Ihab
    Taftaf, Ahmad
    Zhu, Zheng
    Makramalla, Abouelmagd
    Karim, Nagla Abdel
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2019, 2019
  • [38] Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma
    Shoushtari, Alexander N.
    Friedman, Claire F.
    Navid-Azarbaijani, Pedram
    Postow, Michael A.
    Callahan, Margaret K.
    Momtaz, Parisa
    Panageas, Katherine S.
    Wolchok, Jedd D.
    Chapman, Paul B.
    JAMA ONCOLOGY, 2018, 4 (01) : 98 - 101
  • [39] Tocilizumab, ipilimumab, and nivolumab for the treatment of advanced melanoma, non-small cell lung cancer, or urothelial carcinoma
    Diab, A.
    Abdel-Wahab, N.
    Bentebibel, S. E.
    Montazari, E. J.
    Spillson, C. A.
    Ekmekcioglu, S.
    Gao, J.
    Altan, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1456 - S1456
  • [40] Treatment-Free Survival After Nivolumab vs Pembrolizumab vs Nivolumab-Ipilimumab for Advanced Melanoma
    Gupta, Mehul
    Stukalin, Igor
    Meyers, Daniel
    Goutam, Sid
    Heng, Daniel Y. C.
    Cheng, Tina
    Monzon, Jose
    Navani, Vishal
    JAMA NETWORK OPEN, 2023, 6 (06) : E2319607
12345